The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.
Using genetic data, scientists identified several new genetic mutations associated with the rare hereditary vein of Galen malformation. This could help doctors diagnose the condition earlier and provide leads to better treatments. #genetics #raredisease https://t.co/8h09891dsi
A new #genetic study of #acne has discovered 12 new genetic regions associated with it. Interestingly, many of these regions are involved in hair follicle development, suggesting potential mechanisms that could be targeted for new acne treatments. https://t.co/EUzzbfSNLq
People's health data is frequently stolen in large data breaches. Your data is valuable, which is why one of our highest priorities is securing it and letting you benefit from it. https://t.co/jS4DdIqcDU